Treatment of pyoderma gangrenosum

被引:165
作者
Chow, RKP [1 ]
Ho, VC [1 ]
机构
[1] UNIV BRITISH COLUMBIA, DIV DERMATOL, DEPT DERMATOL, VANCOUVER, BC, CANADA
关键词
D O I
10.1016/S0190-9622(96)90285-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Critical to the proper management of pyoderma gangrenosum are correct diagnosis, identification and treatment of any underlying disorder, and the proper choice of topical and systemic therapy. Many agents are available for the treatment of pyoderma gangrenosum. We review the current therapeutic options, their efficacy and side effects, and we offer some guidelines for their proper selection.
引用
收藏
页码:1047 / 1060
页数:14
相关论文
共 199 条
[61]  
FUNG JJ, 1991, TRANSPLANT P, V23, P3105
[62]  
GALUN E, 1986, AM J GASTROENTEROL, V81, P988
[63]  
GARDNER LW, 1972, ARCH DERMATOL, V106, P599
[64]  
GELERNT IM, 1976, MT SINAI J MED, V43, P467
[65]  
GERARD A, 1983, PLASMA THER TRANSFUS, V4, P31
[66]  
GERARD A, 1988, ANN MED INTERNE, V139, P29
[67]   CYCLOSPORINE FOR PYODERMA-GANGRENOSUM [J].
GOLDBERG, NS ;
OTTUSO, P ;
PETRO, J .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1993, 91 (01) :91-93
[68]  
GOLDGRABER MB, 1960, GASTROENTEROLOGY, V39, P94
[69]   INTRALESIONAL STEROID-THERAPY OF PYODERMA-GANGRENOSUM [J].
GOLDSTEIN, F ;
KRAIN, R ;
THORNTON, JJ .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1985, 7 (06) :499-501
[70]   PYODERMA GANGRENOSUM - OCCURRENCE WITH ALTERED CELLULAR-IMMUNITY AND A CIRCULATING SERUM FACTOR [J].
GREENBERG, SJ ;
JEGASOTHY, BV ;
JOHNSON, RB ;
LAZARUS, GS .
ARCHIVES OF DERMATOLOGY, 1982, 118 (07) :498-502